Aspire Health Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aspire Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11296
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aspire Health Inc (Aspire) is a healthcare company which operates a network of outpatient palliative care practices providing medical care for patients with relief from the symptoms, pain, and stress of a serious illness. Its service offerings include symptom and disease management, in-home care and support services; guides patients and caregivers through difficult and complex treatment choices; and provide emotional and spiritual support to patients and their families. The company offers treatments for patients suffering from cancer, congestive heart failure, chronic obstructive pulmonary disease, kidney failure, liver failure, advanced dementia, and amyotrophic lateral sclerosis. The company serves patients, physicians, and health plans across the US. Aspire is headquartered in Nashville, Tennessee, the US.

Aspire Health Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aspire Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Aspire Health Inc, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Aspire Health Raises USD15 Million Series C Venture Financing 9
Aspire Health Raises Funds in Series B Venture Financing 10
Aspire Health Raises US$1 Million In Venture Financing 11
Aspire Health Inc – Key Competitors 12
Aspire Health Inc – Key Employees 13
Aspire Health Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Aspire Health Inc, Pharmaceuticals & Healthcare, Key Facts 2
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aspire Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Aspire Health Raises USD15 Million Series C Venture Financing 9
Aspire Health Raises Funds in Series B Venture Financing 10
Aspire Health Raises US$1 Million In Venture Financing 11
Aspire Health Inc, Key Competitors 12
Aspire Health Inc, Key Employees 13
Aspire Health Inc, Other Locations 14

List of Figures
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aspire Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Aspire Health Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Royal FrieslandCampina N.V.:企業の戦略・SWOT・財務情報
    Royal FrieslandCampina N.V. - Strategy, SWOT and Corporate Finance Report Summary Royal FrieslandCampina N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Viscom AG (V6C):企業の財務・戦略的SWOT分析
    Viscom AG (V6C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Aerosonic, LLC:企業の戦略・SWOT・財務情報
    Aerosonic, LLC - Strategy, SWOT and Corporate Finance Report Summary Aerosonic, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cardiac Science Corp:企業の戦略的SWOT分析
    Cardiac Science Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析
    CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • G4S plc:企業の戦略・SWOT・財務分析
    G4S plc - Strategy, SWOT and Corporate Finance Report Summary G4S plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Japan Foods Co Ltd:企業の戦略・SWOT・財務情報
    Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ViaCyte Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ViaCyte Inc (ViaCyte), formerly Novocell Inc is a regenerative medicine company that centres on the development of cell replacement therapies for the treatment of diabetes. The company’s pipeline products portfolio includes VC-01, which is being developed as a therapy for T1D patients who ha …
  • Cencosud SA:企業のM&A・事業提携・投資動向
    Cencosud SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cencosud SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • China Minsheng Banking Corp Ltd:戦略・SWOT・企業財務分析
    China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • E.ON SE:企業の発電所・SWOT分析2018
    E.ON SE - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Eagle Energy Inc (EGL):石油・ガス:M&Aディール及び事業提携情報
    Summary Eagle Energy Inc (Eagle) is an oil and gas company that acquires for, develops and produces oil and gas reserves through its subsidiaries. It focuses on the acquisition and exploitation of conventional long-life hydrocarbon reserves in on-shore production basins in North America. It acquires …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Siemens Ltd (SIEMENS):企業の財務・戦略的SWOT分析
    Siemens Ltd (SIEMENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Grundfos Holding AS:企業の戦略的SWOT分析
    Grundfos Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Encore Dermatology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Encore Dermatology Inc (Encore Dermatology) is a specialty dermatology company, which develops and commercializes novel prescription medicines and medical devices for the treatment of topical dermatological disorders. The company’s products include HylatopicPlus lotion, a combination of vari …
  • Loral Space & Communications Inc (LORL):企業の財務・戦略的SWOT分析
    Loral Space & Communications Inc (LORL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Votorantim Energia Ltda.:企業の戦略的SWOT分析
    Votorantim Energia Ltda. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • iVascular SLU:企業の製品パイプライン分析2018
    Summary iVascular SLU (iVascular) is a designer and developer of advanced medical devices and implants for the treatment of cardiovascular system disorders. The company offers products in the fields of interventional cardiology, endovascular intervention and interventional neuroradiology including d …
  • QAF Limited:企業の戦略・SWOT・財務情報
    QAF Limited - Strategy, SWOT and Corporate Finance Report Summary QAF Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆